BioCentury
ARTICLE | Financial News

Gradalis raises $24M in series B

January 4, 2013 12:51 AM UTC

Gradalis Inc. (Carrollton, Texas) raised $24 million in a series B round from undisclosed investors. The company's FANG vaccine is in Phase II testing to treat patients with advanced ovarian cancer, a...